Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention

被引：0
|
作者：
Kun Yang
Wenxian Liu
Wei Ren
Shuzheng Lv
机构：
[1] Beijing Institute of Heart,Department of Coronary Care Unit (CCU), Capital Medical University Affiliated Beijing Anzhen Hospital
[2] Lung and Blood Vessel Diseases,Department of Vasculocardiology, Capital Medical University Affiliated Beijing Anzhen Hospital
[3] Beijing Institute of Heart,undefined
[4] Lung and Blood Vessel Diseases,undefined
来源：
International Urology and Nephrology | 2014年 / 46卷
关键词：
Coronary angiography; Percutaneous coronary intervention; Contrast-induced nephropathy; Hydration therapy; Sodium bicarbonate; -Acetylcysteine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1801 / 1807
页数：6
相关论文
共 50 条
  • [31] Brain Natriuretic Peptide for Prevention of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention or Coronary Angiography
    Liu, Jin-Ming
    Xie, Ya-Nan
    Gao, Zi-Han
    Zu, Xiu-Guang
    Li, Yong-Jun
    Hao, Yu-Ming
    Chang, Liang
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (12) : 1607 - 1612
  • [32] Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients
    Yi, Bin
    Mo, Shaoyan
    Jiang, Yumei
    Yi, Dingwu
    Luo, Jinwen
    Chen, Xiang
    Rong, Jian
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2020, 2020
  • [33] Contrast-induced nephropathy in urgent coronary interventions
    Valente, Serafina
    Lazzeri, Chiara
    Giglioli, Cristina
    Margheri, Massimo
    Comeglio, Marco
    Nicolaci, Letizia
    Chechi, Tania
    Gensini, Gian Franco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2006, 7 (10) : 737 - 741
  • [34] Spironolactone for Preventing Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Chronic Kidney Disease
    Lu, Yucheng
    Ni, Weicheng
    Qu, Xiang
    Chen, Changxi
    Shi, Sanling
    Guo, Kun
    Lin, Ken
    Zhou, Hao
    ANGIOLOGY, 2024,
  • [35] Contrast-induced nephropathy after a second percutaneous coronary intervention in patients with chronic kidney disease
    覃雪清
    谭宁
    甘富东
    周颖玲
    陈纪言
    杨大浩
    South China Journal of Cardiology, 2011, 12 (04) : 227 - 240
  • [36] Validation of a New Risk Score to Predict Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
    Tziakas, Dimittios
    Chalikias, Georgios
    Stakos, Dimitrios
    Altun, Armagan
    Sivri, Nasir
    Yetkin, Ertan
    Gur, Mustafa
    Stankovic, Goran
    Mehmedbegovic, Zlatko
    Voudris, Vassilis
    Chatzikyriakou, Sofia
    Garcia-Moll, Xavier
    Serra, Antonio
    Passadakis, Ploumis
    Thodis, Elias
    Vargemezis, Vassilis
    Kaski, Juan Carlos
    Konstantinides, Stavros
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (09): : 1487 - 1493
  • [37] Prevalence of contrast-induced nephropathy after primary percutaneous coronary intervention at a tertiary referral hospital
    Masoomi, Zahra
    Nasirian, Ali Mohammad
    Namazi, Mansoor
    Zangiabadian, Moein
    Dayani, Abdoreza
    Shahidi, Mohammad
    Saghafi, Hossein
    Jolfayi, Amir Ghaffari
    HELIYON, 2024, 10 (04)
  • [38] Can contrast-induced nephropathy after percutaneous coronary intervention be accurately predicted with a risk score?
    Giancarlo Marenzi
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 80 - 81
  • [39] Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention
    Tziakas, D.
    Chalikias, G.
    Altun, A.
    Yetkin, E.
    Stankovic, G.
    Garcia-Moll, X.
    Voudris, V.
    Kaski, J. C.
    Konstantinides, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 126 - 126
  • [40] Efficacy of atorvastatin on renal function in patients with contrast-induced nephropathy after percutaneous coronary intervention
    Li, Heng
    Wang, Hongen
    Ren, Siqi
    Zhou, Ruihong
    JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
12345